Tag: mastectomy

Articles

• Breast reduction surgery and breast cancer
• Lobular breast cancer and LCIS characteristics
• Morphine during surgery might increase risk of metastasis

News

03/09/14

Reconstruction using fat stem cells could promote TN metastasis

01/20/13

Some BC types have up to 11% locoregional recurrence after mastectomy

06/13/12

It's too early to regrow breasts using fat stem cells

12/04/11

Lumpectomy vs. mastectomy rates vary by type of breast cancer

10/22/11

Young breast cancer patients require aggressive treatment

03/22/10

Breast reduction surgery may be combined with lumpectomy for DCIS

03/10/10

Breast tissue of high risk women resembles nontumor tissue of patients

Studies

• Current Trends in Breast Cancer Treatment in Chinese and Chinese American Women Cite
  Putnam G, Williams T, Park S, Grundman K, Goel C, Huffman K, et al. Current Trends in Breast Cancer Treatment in Chinese and Chinese American Women. Annals of Plastic Surgery. Ovid Technologies (Wolters Kluwer Health); 2024; 92:463-468 10.1097/sap.0000000000003826
• Oncoplastic Reduction Mammoplasty: Systematic Review and proportional Meta-analysis of surgical outcomes Cite
  Tekdogan B, Martineau J, Scampa M, Kalbermatten DF, Oranges CM. Oncoplastic Reduction Mammoplasty: Systematic Review and proportional Meta-analysis of surgical outcomes. Journal of Plastic, Reconstructive & Aesthetic Surgery. Elsevier BV; 2023; 10.1016/j.bjps.2023.11.052
• Comparison of Survival Outcomes in Young Patients with Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy Cite
  Huang H, Wei T, Zhang A, Zhang H, Kong L, Li Y, et al. Comparison of Survival Outcomes in Young Patients with Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy. Clinical Breast Cancer. Elsevier BV; 2023; 10.1016/j.clbc.2023.07.010
• 157P Comparison of survival outcomes in young patients with breast cancer receiving contralateral prophylactic mastectomy versus unilateral mastectomy Cite
  Huang H. 157P Comparison of survival outcomes in young patients with breast cancer receiving contralateral prophylactic mastectomy versus unilateral mastectomy. ESMO Open. Elsevier BV; 2023; 8:101497 10.1016/j.esmoop.2023.101497
• Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer Cite
  Lehrberg A, Sebai M, Finn D, Lee D, Karabon P, Kiran S, et al. Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer. The Breast Journal. Hindawi Limited; 2021; 27:753-760 10.1111/tbj.14283
• Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women Cite
  Skjerven HK, Myklebust EM, Korvald C, Porojnicu AC, Kaaresen R, Hofvind S, et al. Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women. European Journal of Surgical Oncology. Elsevier BV; 2023; 49:575-582 10.1016/j.ejso.2022.11.594
• Abstract P1-09-11: Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment Cite
  JANKOWSKI C, Mahiou K, Laura V, Costaz H, padéano M, Causeret S, et al. Abstract P1-09-11: Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:P1-09-11-P1-09-11 10.1158/1538-7445.sabcs22-p1-09-11
• Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review Cite
  Bertozzi S, Londero AP, Xholli A, Azioni G, Di Vora R, Paudice M, et al. Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review. Journal of Clinical Medicine. MDPI AG; 2023; 12:1422 10.3390/jcm12041422
• Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter? Cite
  Lee K, Kim JH, Jeon B, Pyon JK, Mun G, Lee SK, et al. Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 30:1087-1097 10.1245/s10434-022-12389-0
• Survival outcomes for breast conserving surgery versus mastectomy among elderly women with breast cancer Cite
  Xie W, Cao M, Zhong Z, Huang Z, Gao X, Li Z. Survival outcomes for breast conserving surgery versus mastectomy among elderly women with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06725-x
• Surgical management of BRCA-mutation carriers: A single institution experience Cite
  Gentile D, Losurdo A, Sagona A, Zuradelli M, Gatzemeier W, Barbieri E, et al. Surgical management of BRCA-mutation carriers: A single institution experience. European Journal of Surgical Oncology. Elsevier BV; 2022; 48:1706-1712 10.1016/j.ejso.2022.04.024
• Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery Cite
  Orozco JIJ, Keller JK, Chang S, Fancher CE, Grumley JG. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-12190-z
• The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA) Cite
  Ardon AE, George JE, Gupta K, O’Rourke MJ, Seering MS, Tokita HK, et al. The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA). Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 29:4777-4786 10.1245/s10434-022-11724-9
• Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer Cite
  Chen JC, Li Y, Fisher JL, Bhattacharyya O, Tsung A, Bazan JG, et al. Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-11975-6
• Abstract P3-18-02: Breast conservation plus radiotherapy provides superior survival benefit than mastectomy in triple negative breast cancer: A propensity matched national cancer database analysis Cite
  Cao L, Towe CW, Miller ME, Montero AJ, Shenk R. Abstract P3-18-02: Breast conservation plus radiotherapy provides superior survival benefit than mastectomy in triple negative breast cancer: A propensity matched national cancer database analysis. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P3-18-02-P3-18-02 10.1158/1538-7445.sabcs21-p3-18-02
• Abstract P1-24-05: Breast conserving surgery for non-metastatic inflammatory breast cancer: A National Cancer Database (NCDB) study Cite
  Angarita FA, Edge SB, Attwood K, Takabe K, Young J. Abstract P1-24-05: Breast conserving surgery for non-metastatic inflammatory breast cancer: A National Cancer Database (NCDB) study. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P1-24-05-P1-24-05 10.1158/1538-7445.sabcs21-p1-24-05
• Postmastectomy Reconstruction in Male Breast Cancer Cite
  Deldar R, Sayyed AA, Towfighi P, Aminpour N, Sogunro O, Son JD, et al. Postmastectomy Reconstruction in Male Breast Cancer. The Breast Journal. Hindawi Limited; 2022; 2022:1-7 10.1155/2022/5482261
• Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis Cite
  Wang C, Lin Y, Zhu H, Zhou Y, Mao F, Huang X, et al. Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis. Breast Cancer. Springer Science and Business Media LLC; 2021; 10.1007/s12282-021-01312-2
• Delay in Initiating Postmastectomy Radiotherapy is Associated With Inferior Clinical Oncologic Outcomes for High-Risk Breast Cancer Cite
  Chen S, Sun G, Wang S, Fang H, Song Y, Jin J, et al. Delay in Initiating Postmastectomy Radiotherapy is Associated With Inferior Clinical Oncologic Outcomes for High-Risk Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2021; 111:S36-S37 10.1016/j.ijrobp.2021.07.108
• The Trade-Off of Post-Mastectomy Radiotherapy Usage for the Breast Cancer Patients Aged 70 Years or Older: A Study Based on SEER Database Cite
  Lin J, Luo S, Zhang J, Song C. The Trade-Off of Post-Mastectomy Radiotherapy Usage for the Breast Cancer Patients Aged 70 Years or Older: A Study Based on SEER Database. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-966806/v1
• Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center Examination Cite
  McCormick PJ, Assel M, Van Zee KJ, Vickers AJ, Nelson JA, Morrow M, et al. Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center Examination. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 28:5134-5140 10.1245/s10434-021-09722-4
• Breast Conservation Surgery versus Modified Radical Mastectomy in the Management of Non Metastatic Inflammatory Breast Cancer Cite
  Elshinawi ME, Osman AGE, Abdelmoaty KF, Anber WAA. Breast Conservation Surgery versus Modified Radical Mastectomy in the Management of Non Metastatic Inflammatory Breast Cancer. QJM: An International Journal of Medicine. Oxford University Press (OUP); 2021; 114 10.1093/qjmed/hcab097.059
• Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief Cite
  Khoury AL, Keane H, Varghese F, Hosseini A, Mukhtar R, Eder SE, et al. Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00321-w
• Autologous fat grafting for breast reconstruction after breast cancer: a 12-year experience Cite
  Kempa S, Brix E, Heine N, Hösl V, Strauss C, Eigenberger A, et al. Autologous fat grafting for breast reconstruction after breast cancer: a 12-year experience. Archives of Gynecology and Obstetrics. Springer Science and Business Media LLC; 2021; 10.1007/s00404-021-06241-1
• How Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers? Cite
  Garstka M, Henriquez A, Kelly BN, Webster A, Khubchandani JA, Hughes K, et al. How Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 28:5657-5662 10.1245/s10434-021-10445-9
• Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer Cite
  Lehrberg A, Sebai M, Finn D, Lee D, Karabon P, Kiran S, et al. Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer. The Breast Journal. Wiley; 2021; 10.1111/tbj.14283
• Post-mastectomy Radiation Therapy in Triple-Negative Breast Cancer Patients: Analysis of the BEATRICE Trial Cite
  Kayali M, Abi Jaoude J, Mohammed M, Khabsa J, Tfayli A, Poortmans P, et al. Post-mastectomy Radiation Therapy in Triple-Negative Breast Cancer Patients: Analysis of the BEATRICE Trial. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10511-2
• Effect of Contralateral Prophylactic Mastectomy on Overall Survival in Patients with Hormone Receptor Negative Breast Cancer Cite
  Su YC, Zheng X. Effect of Contralateral Prophylactic Mastectomy on Overall Survival in Patients with Hormone Receptor Negative Breast Cancer. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-674088/v1
• Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy? Cite
  Guo L, Xie G, Wang R, Yang L, Sun L, Xu M, et al. Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?. BMC Cancer. Springer Science and Business Media LLC; 2021; 21 10.1186/s12885-021-08429-9
• Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience Cite
  Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, et al. Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 28:2555-2560 10.1245/s10434-020-09042-z
• Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status Cite
  de Boniface J, Szulkin R, Johansson ALV. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status. JAMA Surgery. American Medical Association (AMA); 2021; 10.1001/jamasurg.2021.1438
• Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone Cite
  Nguyen DV, Kim S, Oh Y, Noh OK, Jung Y, Yoon DS, et al. Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone. Research Square; 2021; 10.21203/rs.3.rs-209244/v1
• Screening and Preventative Strategies for Patients at High Risk for Breast Cancer Cite
  Ter-Minassian M, Schaeffer ML, Jefferson CR, Shapiro SC, Suwannarat P, Visvanathan K. Screening and Preventative Strategies for Patients at High Risk for Breast Cancer. JCO Oncology Practice. American Society of Clinical Oncology (ASCO); 2021;:OP.20.00262 10.1200/op.20.00262
• The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer Cite
  Partain N, Postlewait LM, Teshome M, Rosso K, Hall C, Song J, et al. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-020-09392-8
• Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery? Cite
  Postlewait LM, Teshome M, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, et al. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 27:4603-4612 10.1245/s10434-020-08891-y
• Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study Cite
  Simons JM, Jacobs JG, Roijers JP, Beek MA, Boonman-de Winter LJM, Rijken AM, et al. Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05966-y
• Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence Cite
  Lee K, Kim S, Jeon B, Pyon JK, Mun G, Ryu JM, et al. Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence. JAMA Surgery. American Medical Association (AMA); 2020; 155:1132 10.1001/jamasurg.2020.4124
• Spatial location of local recurrences after mastectomy: a systematic review Cite
  Kaidar-Person O, Poortmans P, Offersen BV, Siesling S, Sklair-Levy M, Meattini I, et al. Spatial location of local recurrences after mastectomy: a systematic review. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 183:263-273 10.1007/s10549-020-05774-4
• Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer Cite
  Macfie R, Aks C, Panwala K, Johnson N, Jennifer Garreau . Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer. The American Journal of Surgery. Elsevier BV; 2020; 10.1016/j.amjsurg.2020.04.016
• Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review Cite
  Sauder CA, Bateni SB, Davidson AJ, Nishijima DK. Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review. Clinical Breast Cancer. Elsevier BV; 2020; 20:e309-e314 10.1016/j.clbc.2019.12.004
• Radiotherapy after mastectomy has significant survival benefits for inflammatory breast cancer: a SEER population-based retrospective study Cite
  Li Z, Zhang M, Yang Y, Zhou Z, Liu Y, Li H, et al. Radiotherapy after mastectomy has significant survival benefits for inflammatory breast cancer: a SEER population-based retrospective study. PeerJ. PeerJ; 2020; 8:e8512 10.7717/peerj.8512
• Long-term Results After Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience Cite
  GIANI M, RENDA I, VALLARIO A, TAVELLA K, VILLANUCCI A, NORI J, et al. Long-term Results After Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience. Anticancer Research. Anticancer Research USA Inc.; 2020; 40:1079-1085 10.21873/anticanres.14046
• Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers Cite
  Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA, Noguès C, et al. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Research. Springer Science and Business Media LLC; 2020; 22 10.1186/s13058-020-1247-4
• Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015 Cite
  Kurian AW, Canchola AJ, Ma CS, Clarke CA, Gomez SL. Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015. Cancer. Wiley; 2019; 126:958-970 10.1002/cncr.32618
• Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis Cite
  Kupstas AR, Hoskin TL, Day CN, Habermann EB, Boughey JC. Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2019; 26:3240-3249 10.1245/s10434-019-07566-7
• Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer Cite
  Chen H, Zhang P, Zhang M, Wang M, Bai F, Wu K. Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer. Journal of Surgical Research. Elsevier BV; 2019; 239:224-232 10.1016/j.jss.2019.02.002
• The role of post‐mastectomy radiotherapy in elderly patients with 1‐3 positive lymph nodes breast cancer: An International Retrospective Double‐Center Study Cite
  Cao L, G. Adedjouma N, Xu C, Shen K, Laki F, Chen J, et al. The role of post‐mastectomy radiotherapy in elderly patients with 1‐3 positive lymph nodes breast cancer: An International Retrospective Double‐Center Study. The Breast Journal. Wiley; 2019; 25:107-111 10.1111/tbj.13163
• Long-term Follow-up of Autologous Fat Transfer vs Conventional Breast Reconstruction and Association With Cancer Relapse in Patients With Breast Cancer Cite
  Krastev T, van Turnhout A, Vriens E, Smits L, van der Hulst R. Long-term Follow-up of Autologous Fat Transfer vs Conventional Breast Reconstruction and Association With Cancer Relapse in Patients With Breast Cancer. JAMA Surgery. American Medical Association (AMA); 2019; 154:56 10.1001/jamasurg.2018.3744
• Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer Cite
  Geers J, Wildiers H, Van Calster K, Laenen A, Floris G, Vandevoort M, et al. Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4912-6
• Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis Cite
  Chen J, Wu X, Christos P, Yan W, Ravi A. Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis. Clinical Breast Cancer. Elsevier BV; 2018; 18:e967-e973 10.1016/j.clbc.2018.05.002
• Risk-reducing mastectomy for the prevention of primary breast cancer Cite
  Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database of Systematic Reviews. Wiley; 2018; 10.1002/14651858.cd002748.pub4
• Routine histopathological examination after female-to-male gender-confirming mastectomy Cite
  Van Renterghem SMJ, Van Dorpe J, Monstrey SJ, Defreyne J, Claes KEY, Praet M, et al. Routine histopathological examination after female-to-male gender-confirming mastectomy. British Journal of Surgery. Wiley; 2018; 105:885-892 10.1002/bjs.10794
• Direct-to-Implant Breast Reconstruction in Women Older than 65 Years Cite
  Knackstedt R, Gatherwright J, Moreira A. Direct-to-Implant Breast Reconstruction in Women Older than 65 Years. Plastic and Reconstructive Surgery. Ovid Technologies (Wolters Kluwer Health); 2018; 141:251-256 10.1097/prs.0000000000004015
• Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Cite
  Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:561-564 10.1200/jco.2016.71.0947
• Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma Cite
  Agarwal S, Pappas L, Agarwal J. Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma. Cancer Management and Research. Informa UK Limited; 2017; Volume 9:649-656 10.2147/cmar.s148456
• The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy Cite
  Giannakeas V, Narod SA. The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 167:263-267 10.1007/s10549-017-4476-1
• A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18 Cite
  Chen H, Wu K, Wang M, Wang F, Zhang M, Zhang P. A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18. The Breast. Elsevier BV; 2017; 35:48-54 10.1016/j.breast.2017.06.002
• Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ Cite
  Park HL, Chang J, Lal G, Lal K, Ziogas A, Anton-Culver H. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ. Clinical Breast Cancer. Elsevier BV; 2018; 18:e179-e185 10.1016/j.clbc.2017.08.001
• Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy? Cite
  Miller ME, Muhsen S, Olcese C, Patil S, Morrow M, Van Zee KJ. Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2017; 24:2889-2897 10.1245/s10434-017-5931-2
• Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival Cite
  Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, et al. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival. Breast Cancer Research. Springer Science and Business Media LLC; 2017; 19 10.1186/s13058-017-0870-1
• Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy Cite
  Xie Z, Sun J, Hu Z, Wu Y, Liu P, Tang J, et al. Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy. European Journal of Cancer. Elsevier BV; 2017; 82:6-15 10.1016/j.ejca.2017.05.030
• Decreased contralateral breast volume after mastectomy, adjuvant chemotherapy, and anti-estrogen therapy, in particular in breasts with high density Cite
  Ishii N, Ando J, Harao M, Takemae M, Kishi K. Decreased contralateral breast volume after mastectomy, adjuvant chemotherapy, and anti-estrogen therapy, in particular in breasts with high density. Journal of Plastic, Reconstructive & Aesthetic Surgery. Elsevier BV; 2017; 70:1363-1368 10.1016/j.bjps.2017.05.013
• Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients Cite
  He X, Ye F, Zhao B, Tang H, Wang J, Xiao X, et al. Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0173862 10.1371/journal.pone.0173862
• Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era Cite
  Miyashita M, Tada H, Suzuki A, Watanabe G, Hirakawa H, Amari M, et al. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era. Surgical Oncology. Elsevier BV; 2017; 26:163-170 10.1016/j.suronc.2017.03.003
• Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis Cite
  Abrams MJ, Koffer PP, Wazer DE, Hepel JT. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2017; 98:384-391 10.1016/j.ijrobp.2017.02.007
• Survival after Breast-Conserving Surgery with Whole Breast or Partial Breast Irradiation in Women with Early Stage Breast Cancer: A SEER Data-base Analysis Cite
  Grover S, Nurkic S, Diener-West M, Showalter SL. Survival after Breast-Conserving Surgery with Whole Breast or Partial Breast Irradiation in Women with Early Stage Breast Cancer: A SEER Data-base Analysis. The Breast Journal. Wiley; 2016; 23:292-298 10.1111/tbj.12729
• Cancer Risk after Fat Transfer Cite
  Myckatyn TM, Wagner IJ, Mehrara BJ, Crosby MA, Park JE, Qaqish BF, et al. Cancer Risk after Fat Transfer. Plastic and Reconstructive Surgery. Ovid Technologies (Wolters Kluwer Health); 2017; 139:11-18 10.1097/prs.0000000000002838
• Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition Cite
  van Helmond N, Steegers MA, Filippini-de Moor GP, Vissers KC, Wilder-Smith OH. Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0166601 10.1371/journal.pone.0166601
• The impact of immediate breast reconstruction after mastectomy on time to first adjuvant treatment in women with breast cancer in a community setting Cite
  Henry L, Morris L, Downs R, Schwarz R. The impact of immediate breast reconstruction after mastectomy on time to first adjuvant treatment in women with breast cancer in a community setting. The American Journal of Surgery. Elsevier BV; 2017; 213:534-538 10.1016/j.amjsurg.2016.11.004
• Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case–Control Study Cite
  Ryu JM, Park S, Paik H, Nam SJ, Kim SW, Lee SK, et al. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case–Control Study. Clinical Breast Cancer. Elsevier BV; 2017; 17:204-210 10.1016/j.clbc.2016.10.009
• Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger Cite
  Plichta JK, Rai U, Tang R, Coopey SB, Buckley JM, Gadd MA, et al. Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2016; 23:3212-3220 10.1245/s10434-016-5404-z
• 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study Cite
  van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. The Lancet Oncology. Elsevier BV; 2016; 17:1158-1170 10.1016/s1470-2045(16)30067-5
• Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients Cite
  Laurberg T, Lyngholm CD, Christiansen P, Alsner J, Overgaard J. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients. Radiotherapy and Oncology. Elsevier BV; 2016; 120:98-106 10.1016/j.radonc.2016.05.006
• Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer Cite
  Loveland-Jones C, Lin H, Shen Y, Bedrosian I, Shaitelman S, Kuerer H, et al. Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2016; 95:1218-1225 10.1016/j.ijrobp.2016.02.065
• A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction Cite
  Warschkow R, Cerny T, Schmied BM, Güller U, Thuerlimann B, Joerger M. A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. British Journal of Cancer. Springer Science and Business Media LLC; 2016; 115:80-84 10.1038/bjc.2016.108
• Clinical and neurophysiological evaluation of persistent sensory disturbances in breast cancer women after mastectomy with or without radiotherapy Cite
  Hojan K, Wojtysiak M, Huber J, Molińska-Glura M, Wiertel-Krawczuk A, Milecki P. Clinical and neurophysiological evaluation of persistent sensory disturbances in breast cancer women after mastectomy with or without radiotherapy. European Journal of Oncology Nursing. Elsevier BV; 2016; 23:8-14 10.1016/j.ejon.2016.03.007
• Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study Cite
  Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean Journal of Anesthesiology. The Korean Society of Anesthesiologists; 2016; 69:126 10.4097/kjae.2016.69.2.126
• Abstract P6-10-17: Rates of prophylactic surgeries among BRCA 1 or 2 mutation carriers: A single institution experience Cite
  Raphael J, Hewitt P, Graham T, Ott K, Mancuso T, Lorentz J, et al. Abstract P6-10-17: Rates of prophylactic surgeries among BRCA 1 or 2 mutation carriers: A single institution experience. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p6-10-17
• Comparison of Long-Term Outcomes of Postmastectomy Radiotherapy between Breast Cancer Patients with and without Immediate Flap Reconstruction Cite
  Lee H, Hou M, Wei S, Lin S, Luo K, Huang M, et al. Comparison of Long-Term Outcomes of Postmastectomy Radiotherapy between Breast Cancer Patients with and without Immediate Flap Reconstruction. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0148318 10.1371/journal.pone.0148318
• Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic Review and Meta-Analysis Cite
  Pan X, Qu S, Jiang Y, Zhu X. Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic Review and Meta-Analysis. Breast Care. S. Karger AG; 2015; 10:413-416 10.1159/000441436
• Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database Cite
  Tseng YD, Uno H, Hughes ME, Niland JC, Wong Y, Theriault R, et al. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015; 93:622-630 10.1016/j.ijrobp.2015.07.006
• Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis Cite
  Yoshida A, Takahashi O, Okumura Y, Arima N, Nakatsukasa K, Tanabe M, et al. Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2016; 42:474-480 10.1016/j.ejso.2016.01.011
• Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics Cite
  Hofvind S, Holen Å, Aas T, Roman M, Sebuødegård S, Akslen L. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2015; 41:1417-1422 10.1016/j.ejso.2015.07.002
• Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy Cite
  Xin F, Yu Y, Yang Z, Hou L, Mao J, Xia L, et al. Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy. Tumor Biology. Springer Science and Business Media LLC; 2016; 37:8445-8454 10.1007/s13277-015-4640-3
• Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women Cite
  Frank S, Dupont A, Teixeira L, Porcher R, De Roquancourt A, Giacchetti S, et al. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women. The Breast. Elsevier BV; 2016; 25:51-56 10.1016/j.breast.2015.10.008
• Postmastectomy radiation therapy in T3 node-negative breast cancer Cite
  Elmore L, Deshpande A, Daly M, Margenthaler JA. Postmastectomy radiation therapy in T3 node-negative breast cancer. Journal of Surgical Research. Elsevier BV; 2015; 199:90-96 10.1016/j.jss.2015.04.012
• No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study Cite
  Nordenskjöld A, Fohlin H, Albertsson P, Arnesson L, Chamalidou C, Einbeigi Z, et al. No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study. Annals of Oncology. Elsevier BV; 2015; 26:1149-1154 10.1093/annonc/mdv159
• Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes Cite
  He Z, Wu S, Zhou J, Li F, Lin Q, Lin H, et al. Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0119105 10.1371/journal.pone.0119105
• Effect of Implant vs. Tissue Reconstruction on Cancer Specific Survival Varies by Axillary Lymph Node Status in Breast Cancer Patients Cite
  Ouyang Q, Zhu L, Chen K, Su F. Effect of Implant vs. Tissue Reconstruction on Cancer Specific Survival Varies by Axillary Lymph Node Status in Breast Cancer Patients. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0118161 10.1371/journal.pone.0118161
• Postmastectomy Radiation for N2/N3 Breast Cancer: Factors Associated with Low Compliance Rate Cite
  Chu QD, Caldito G, Miller JK, Townsend B. Postmastectomy Radiation for N2/N3 Breast Cancer: Factors Associated with Low Compliance Rate. Journal of the American College of Surgeons. Elsevier BV; 2015; 220:659-669 10.1016/j.jamcollsurg.2014.12.045
• Continuous paravertebral block for postoperative pain compared to general anaesthesia and wound infiltration for major oncological breast surgery Cite
  Bouman EAC, Theunissen M, Kessels AG, Keymeulen KB, Joosten EA, Marcus MA, et al. Continuous paravertebral block for postoperative pain compared to general anaesthesia and wound infiltration for major oncological breast surgery. SpringerPlus. Springer Science and Business Media LLC; 2014; 3 10.1186/2193-1801-3-517
• Should Women Younger Than 40 Years of Age With Invasive Breast Cancer Have a Mastectomy?: 15-Year Outcomes in a Population-Based Cohort Cite
  Cao JQ, Truong PT, Olivotto IA, Olson R, Coulombe G, Keyes M, et al. Should Women Younger Than 40 Years of Age With Invasive Breast Cancer Have a Mastectomy?: 15-Year Outcomes in a Population-Based Cohort. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014; 90:509-517 10.1016/j.ijrobp.2014.06.041
• Survival Outcomes After Contralateral Prophylactic Mastectomy: A Decision Analysis Cite
  Portschy PR, Kuntz KM, Tuttle TM. Survival Outcomes After Contralateral Prophylactic Mastectomy: A Decision Analysis. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2014; 106:dju160-dju160 10.1093/jnci/dju160
• Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment Cite
  McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK, et al. Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014; 89:392-398 10.1016/j.ijrobp.2014.02.013
• Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials Cite
  EBCTCG (Early Breast Cancer Trialists' Collaborative Group) . Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. The Lancet. Elsevier BV; 2014; 383:2127-2135 10.1016/s0140-6736(14)60488-8
• Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis Cite
  Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N, et al. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ. BMJ; 2014; 348:g226-g226 10.1136/bmj.g226
• Post-Mastectomy Radiotherapy for Breast Cancer Patients with T1-T2 and 1-3 Positive Lymph Nodes: a Meta-Analysis Cite
  Li Y, Moran MS, Huo Q, Yang Q, Haffty BG. Post-Mastectomy Radiotherapy for Breast Cancer Patients with T1-T2 and 1-3 Positive Lymph Nodes: a Meta-Analysis. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e81765 10.1371/journal.pone.0081765
• Long-term oncological results after 400 skin-sparing mastectomies Cite
  Missana M, Laurent I, Germain M, Lucas S, Barreau L. Long-term oncological results after 400 skin-sparing mastectomies. Journal of Visceral Surgery. Elsevier BV; 2013; 150:313-320 10.1016/j.jviscsurg.2013.09.011
• Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial Cite
  van Hezewijk M, Bastiaannet E, Putter H, Scholten AN, Liefers G, Rea D, et al. Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial. Radiotherapy and Oncology. Elsevier BV; 2013; 108:190-196 10.1016/j.radonc.2013.08.020
• Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study Cite
  Sprague BL, McLaughlin V, Hampton JM, Newcomb PA, Trentham-Dietz A. Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 141:145-154 10.1007/s10549-013-2670-3
• Delay to Curative Surgery Greater than 12 Weeks Is Associated with Increased Mortality in Patients with Colorectal and Breast Cancer but Not Lung or Thyroid Cancer Cite
  Shin DW, Cho J, Kim SY, Guallar E, Hwang SS, Cho B, et al. Delay to Curative Surgery Greater than 12 Weeks Is Associated with Increased Mortality in Patients with Colorectal and Breast Cancer but Not Lung or Thyroid Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2013; 20:2468-2476 10.1245/s10434-013-2957-y
• Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction Cite
  Kneubil M, Brollo J, Botteri E, Curigliano G, Rotmensz N, Goldhirsch A, et al. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2013; 39:260-265 10.1016/j.ejso.2012.12.004
• Seroma Formation after Breast Cancer Surgery: What We Have Learned in the Last Two Decades Cite
  Srivastava V, Basu S, Shukla VK. Seroma Formation after Breast Cancer Surgery: What We Have Learned in the Last Two Decades. Journal of Breast Cancer. Korean Breast Cancer Society; 2012; 15:373 10.4048/jbc.2012.15.4.373
• Outcomes in Patients Treated With Mastectomy for Ductal Carcinoma In Situ Cite
  Owen D, Tyldesley S, Alexander C, Speers C, Truong P, Nichol A, et al. Outcomes in Patients Treated With Mastectomy for Ductal Carcinoma In Situ. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2013; 85:e129-e134 10.1016/j.ijrobp.2012.10.020
• Should Breast Density Influence Patient Selection for Breast-Conserving Surgery? Cite
  Kapoor NS, Eaton A, King TA, Patil S, Stempel M, Morris E, et al. Should Breast Density Influence Patient Selection for Breast-Conserving Surgery?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 20:600-606 10.1245/s10434-012-2604-z
• The Impact of the Size of Nodal Metastases on Recurrence Risk in Breast Cancer Patients With 1-3 Positive Axillary Nodes After Mastectomy Cite
  Harris EE, Freilich J, Lin H, Chuong M, Acs G. The Impact of the Size of Nodal Metastases on Recurrence Risk in Breast Cancer Patients With 1-3 Positive Axillary Nodes After Mastectomy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2013; 85:609-614 10.1016/j.ijrobp.2012.05.050
• Evaluating the Feasibility of Extended Partial Mastectomy and Immediate Reduction Mammoplasty Reconstruction as an Alternative to Mastectomy Cite
  Chang EI, Peled AW, Foster RD, Lin C, Zeidler KR, Ewing CA, et al. Evaluating the Feasibility of Extended Partial Mastectomy and Immediate Reduction Mammoplasty Reconstruction as an Alternative to Mastectomy. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2012; 255:1151-1157 10.1097/sla.0b013e31824f9769
• Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report Cite
  Karlsson P, Cole B, Chua B, Price K, Lindtner J, Collins J, et al. Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report. Annals of Oncology. Elsevier BV; 2012; 23:2852-2858 10.1093/annonc/mds118
• Adipose tissue and breast epithelial cells: A dangerous dynamic duo in breast cancer Cite
  Wang Y, Lehuédé C, Laurent V, Dirat B, Dauvillier S, Bochet L, et al. Adipose tissue and breast epithelial cells: A dangerous dynamic duo in breast cancer. Cancer Letters. Elsevier BV; 2012; 324:142-151 10.1016/j.canlet.2012.05.019
• The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression Cite
  Martin-Padura I, Gregato G, Marighetti P, Mancuso P, Calleri A, Corsini C, et al. The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression. Cancer Research. American Association for Cancer Research (AACR); 2011; 72:325-334 10.1158/0008-5472.can-11-1739
• Implanted adipose progenitor cells as physicochemical regulators of breast cancer Cite
  Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2012; 109:9786-9791 10.1073/pnas.1121160109
• Biology, Treatment, and Outcome in Very Young and Older Women with DCIS Cite
  Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, et al. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 19:3777-3784 10.1245/s10434-012-2413-4
• Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy? Cite
  Hamamoto Y, Ohsumi S, Aogi K, Shinohara S, Nakajima N, Kataoka M, et al. Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?. Breast Cancer. Springer Science and Business Media LLC; 2012; 21:177-182 10.1007/s12282-012-0369-7
• Prognostic Value of Molecular Subtypes, Ki67 Expression and Impact of Postmastectomy Radiation Therapy in Breast Cancer Patients With Negative Lymph Nodes After Mastectomy Cite
  Selz J, Stevens D, Jouanneau L, Labib A, Le Scodan R. Prognostic Value of Molecular Subtypes, Ki67 Expression and Impact of Postmastectomy Radiation Therapy in Breast Cancer Patients With Negative Lymph Nodes After Mastectomy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 84:1123-1132 10.1016/j.ijrobp.2012.02.047
• Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? Cite
  Trovo M, Durofil E, Polesel J, Roncadin M, Perin T, Mileto M, et al. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation?. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 83:e153-e157 10.1016/j.ijrobp.2011.12.050
• Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial Cite
  Litière S, Werutsky G, Fentiman IS, Rutgers E, Christiaens M, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. The Lancet Oncology. Elsevier BV; 2012; 13:412-419 10.1016/s1470-2045(12)70042-6
• The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty Cite
  Dogan L, Gulcelik Ma, Bulut M, Karaman N, Kiziltan G, Ozaslan C. The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty. Journal of Breast Cancer. Korean Breast Cancer Society; 2011; 14:219 10.4048/jbc.2011.14.3.219
• The role of oncoplastic therapeutic mammoplasty in breast cancer surgery- A review Cite
  Iwuchukwu O, Harvey J, Dordea M, Critchley A, Drew P. The role of oncoplastic therapeutic mammoplasty in breast cancer surgery- A review. Surgical Oncology. Elsevier BV; 2012; 21:133-141 10.1016/j.suronc.2011.01.002
• Widespread Mechanical Pain Hypersensitivity as a Sign of Central Sensitization after Breast Cancer Surgery: Comparison between Mastectomy and Lumpectomy Cite
  Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-las-Peñas C, Del-Moral-Ávila R, Menjón-Beltrán S, Arroyo-Morales M. Widespread Mechanical Pain Hypersensitivity as a Sign of Central Sensitization after Breast Cancer Surgery: Comparison between Mastectomy and Lumpectomy. Pain Medicine. Oxford University Press (OUP); 2011; 12:72-78 10.1111/j.1526-4637.2010.01027.x
• Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1–3 Positive Lymph Nodes? Cite
  Offersen BV, Brodersen H, Nielsen MM, Overgaard J, Overgaard M. Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1–3 Positive Lymph Nodes?. Breast Care. S. Karger AG; 2011; 6:347-351 10.1159/000333250
• Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype Cite
  Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 133:831-841 10.1007/s10549-011-1891-6
• Twenty-five year results of the national cancer institute randomized breast conservation trial Cite
  Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, et al. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:197-203 10.1007/s10549-011-1867-6
• Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique? Cite
  Wasif N, McCullough AE, Gray RJ, Pockaj BA. Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique?. Journal of Surgical Oncology. Wiley; 2011; 105:586-590 10.1002/jso.22132
• Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation Cite
  Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, et al. Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2011; 18:3164-3173 10.1245/s10434-011-1920-z
• Breast cancer in very young women Cite
  Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J. Breast cancer in very young women. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1030-1037 10.1016/j.ejso.2011.08.133
• Prevalence of lymphoedema more than five years after breast cancer treatment Cite
  Lopez Penha T, Slangen J, Heuts E, Voogd A, Von Meyenfeldt M. Prevalence of lymphoedema more than five years after breast cancer treatment. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1059-1063 10.1016/j.ejso.2011.09.001
• Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger. Cite
  Buckley JM, Coopey S, Samphao S, Specht MC, Hughes KS, Gadd M, et al. Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:70-70 10.1200/jco.2011.29.27_suppl.70
• Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Cite
  Yerushalmi R, Tyldesley S, Woods R, Kennecke H, Speers C, Gelmon K. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?. Annals of Oncology. Elsevier BV; 2011; 23:876-881 10.1093/annonc/mdr326
• Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer Cite
  Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, et al. Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer. Oncology. S. Karger AG; 2011; 80:341-349 10.1159/000330203
• Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients Cite
  Fitzal F, Mittlboeck M, Steger G, Bartsch R, Rudas M, Dubsky P, et al. Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2011; 19:519-526 10.1245/s10434-011-1879-9
• Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation Cite
  Panoff JE, Hurley J, Takita C, Reis IM, Zhao W, Sujoy V, et al. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 128:899-906 10.1007/s10549-011-1495-1
• Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy Cite
  Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, et al. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer. Wiley; 2010; 117:916-924 10.1002/cncr.25505
• Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast Cite
  Biglia N, Bounous V, Martincich L, Panuccio E, Liberale V, Ottino L, et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:199-204 10.1016/j.ejso.2010.12.011
• The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Cite
  Gabos Z, Thoms J, Ghosh S, Hanson J, Deschênes J, Sabri S, et al. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:187-194 10.1007/s10549-010-1135-1
• Locoregional Recurrence in Patients With Triple-Negative Breast Cancer Cite
  Dragun AE, Pan J, Rai SN, Kruse B, Jain D. Locoregional Recurrence in Patients With Triple-Negative Breast Cancer. American Journal of Clinical Oncology. Ovid Technologies (Wolters Kluwer Health); 2011; 34:231-237 10.1097/coc.0b013e3181dea993
• Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years Cite
  van der Sangen MJC, van de Wiel FMM, Poortmans PMP, Tjan-Heijnen VCG, Nieuwenhuijzen GAP, Roumen RMH, et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 127:207-215 10.1007/s10549-010-1110-x
• Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis Cite
  Forget P, Vandenhende J, Berliere M, Machiels J, Nussbaum B, Legrand C, et al. Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis. Anesthesia & Analgesia. Ovid Technologies (Wolters Kluwer Health); 2010; 110:1630-1635 10.1213/ane.0b013e3181d2ad07
• Conservative surgery in patients with multifocal/multicentric breast cancer Cite
  Gentilini O, Botteri E, Rotmensz N, Da Lima L, Caliskan M, Garcia-Etienne CA, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2008; 113:577-583 10.1007/s10549-008-9959-7
• 500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival? Cite
  Heemskerk-Gerritsen B, Hooning M, Jager A, Tilanus-Linthorst M, Bartels C, van den Ouweland A, et al. 500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:206 10.1016/s1359-6349(10)70521-8
• The Use of Oncoplastic Reduction Techniques to Reconstruct Partial Mastectomy Defects in Women with Ductal Carcinoma In Situ Cite
  Song HM, Styblo TM, Carlson GW, Losken A. The Use of Oncoplastic Reduction Techniques to Reconstruct Partial Mastectomy Defects in Women with Ductal Carcinoma In Situ. The Breast Journal. Wiley; 2010; 16:141-146 10.1111/j.1524-4741.2009.00891.x
• Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile Cite
  Graham K, de las Morenas A, Tripathi A, King C, Kavanah M, Mendez J, et al. Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. British Journal of Cancer. Springer Science and Business Media LLC; 2010; 102:1284-1293 10.1038/sj.bjc.6605576
• Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients Cite
  Bedrosian I, Hu C, Chang GJ. Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:401-409 10.1093/jnci/djq018
• Breast cancer in women under 40 years of age: A series of 57 cases from Northern Ireland Cite
  McAree B, O'Donnell M, Spence A, Lioe T, McManus D, Spence R. Breast cancer in women under 40 years of age: A series of 57 cases from Northern Ireland. The Breast. Elsevier BV; 2010; 19:97-104 10.1016/j.breast.2009.12.002
• Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes Cite
  Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:170-178 10.1093/jnci/djp482
• Reduction mammaplasty: An advantageous option for breast conserving surgery in large-breasted patients Cite
  Hernanz F, Regaño S, Vega A, Gómez Fleitas M. Reduction mammaplasty: An advantageous option for breast conserving surgery in large-breasted patients. Surgical Oncology. Elsevier BV; 2010; 19:e95-e102 10.1016/j.suronc.2009.08.001
• A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women Cite
  Fryzek JP, Ye W, Nyrén O, Tarone RE, Lipworth L, McLaughlin JK. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2005; 97:131-134 10.1007/s10549-005-9099-2
• Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy Cite
  Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, et al. Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy. Journal of the American College of Surgeons. Elsevier BV; 2009; 209:746-752 10.1016/j.jamcollsurg.2009.08.010
• Mucinous Breast Carcinoma: Occult Multifocality/Multicentricity in a Favorable Disease. Cite
  Perkins G, Babiera G, Bedrosian I, Gonzalez-Angulo A, Whitman G, Yang W, et al. Mucinous Breast Carcinoma: Occult Multifocality/Multicentricity in a Favorable Disease.. Poster Session Abstracts. American Association for Cancer Research; 2009; 10.1158/0008-5472.sabcs-09-4117
• Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women Cite
  Kouri EM, He Y, Winer EP, Keating NL. Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 121:743-751 10.1007/s10549-009-0643-3
• Breast Cancer Recurrence in Older Women Five to Ten Years after Diagnosis Cite
  Bosco JL, Lash TL, Prout MN, Buist DS, Geiger AM, Haque R, et al. Breast Cancer Recurrence in Older Women Five to Ten Years after Diagnosis. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2009; 18:2979-2983 10.1158/1055-9965.epi-09-0607
• Can Anesthetic Technique for Primary Breast Cancer Surgery Affect Recurrence or Metastasis? Cite
  Exadaktylos A, Buggy D, Moriarty D, Mascha E, Sessler D. Can Anesthetic Technique for Primary Breast Cancer Surgery Affect Recurrence or Metastasis?. Anesthesiology. Ovid Technologies (Wolters Kluwer Health); 2006; 105:660-664 10.1097/00000542-200610000-00008